Mereo Biopharma Group Plc(MREO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MREO Mereo Biopharma Group Plc

盘后交易 10-26 19:30:49 EDT

0.2750

-0.0067

-2.38%

盘后0.2750

+0.00000.00%

19:30 EDT

最高0.2865	最低0.2750	成交量31.32万
今开0.2789	昨收0.2817	日振幅4.08%
总市值4,376万	流通市值3,438万	总股本1.59亿
成交额8.76万	换手率0.25%	流通股本1.25亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MREO","market":"US","secType":"STK","nameCN":"Mereo Biopharma Group Plc","latestPrice":0.275,"timestamp":1793044800000,"preClose":0.2817,"halted":0,"volume":313239,"hourTrading":{"tag":"盘后","latestPrice":0.275,"preClose":0.275,"latestTime":"19:30 EDT","volume":64,"amount":17.67149952,"timestamp":1793057403519,"change":0,"changeRate":0,"amplitude":0.02},"delay":0,"changeRate":-0.02378416755413555,"floatShares":125000000,"shares":159131700,"eps":-0.1753,"marketStatus":"盘后交易","change":-0.0067,"latestTime":"10-26 19:30:49 EDT","open":0.2789,"high":0.2865,"low":0.275,"amount":87607.58251592999,"amplitude":0.040824,"askPrice":0.3214,"askSize":100,"bidPrice":0.27,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-0.1753,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1793059200000},"marketStatusCode":4,"adr":0,"adrRate":5,"listingDate":1556078400000,"exchange":"NASDAQ","adjPreClose":0.2817,"preHourTrading":{"tag":"盘前","latestPrice":0.2801,"preClose":0.2817,"latestTime":"09:12 EDT","volume":7283,"amount":2015.8094237199998,"timestamp":1793020357885,"change":-0.0016,"changeRate":-0.00568,"amplitude":0.058573},"postHourTrading":{"tag":"盘后","latestPrice":0.275,"preClose":0.275,"latestTime":"19:30 EDT","volume":64,"amount":17.67149952,"timestamp":1793057403519,"change":0,"changeRate":0,"amplitude":0.02},"volumeRatio":0.691981,"impliedVol":1.131,"impliedVolPercentile":0.5538},"requestUrl":"/m/hq/s/MREO","defaultTab":"news","newsList":[{"id":"1102370368","title":"Sentynl Therapeutics 与 Mereo Biopharma 达成 Alvelestat 针对 α-1 抗胰蛋白酶缺乏相关肺病的期权与许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1102370368","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102370368?lang=zh_cn&edition=full","pubTime":"2026-08-11 21:26","pubTimestamp":1786454811,"startTime":"0","endTime":"0","summary":"Mereo Biopharma Group Plc 于 8 月 11 日宣布，其与 Sentynl Therapeutics 已签署一项针对 Alvelestat 的期权与许可协议。该药物旨在治疗 α-1 抗胰蛋白酶缺乏相关肺病 。一旦行使该期权，Sentynl 将负责 Alvelestat 在美国的商业化工作。而 Mereo Biopharma 则保留该药物在全球其他地区的全部权利。作为交易的一部分，Mereo Biopharma 将有权获得高达 4000 万美元的付款。此外，基于美国市场的销售额，该公司还将获得两位数的分级特许权使用费。这笔交易为双方的合作奠定了基础，旨在推动这一潜在疗法的开发与市场拓展。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MREO","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144931274","title":"Mereo BioPharma 第二季度运营收入达 -703万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1144931274","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144931274?lang=zh_cn&edition=full","pubTime":"2026-08-11 20:30","pubTimestamp":1786451425,"startTime":"0","endTime":"0","summary":"Mereo BioPharma Group Plc (MREO) 公布了其第二季度财务数据。数据显示，该公司在报告期内，税前利润为 -700.5万美元。这一数字，无疑揭示了公司在特定阶段所面临的财务挑战。具体来看，运营收入方面，录得 -703万美元，同样呈现出负值。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","MREO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138173670","title":"Mereo BioPharma首季净亏损670万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138173670","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138173670?lang=zh_cn&edition=full","pubTime":"2026-05-12 19:43","pubTimestamp":1778586213,"startTime":"0","endTime":"0","summary":"Mereo BioPharma Group Plc公布第一季度财务数据，其运营亏损达到876.6万美元。同期，公司净亏损为671.9万美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","MREO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517219192","title":"Mereo Biopharma Group Plc盘中异动 快速下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517219192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517219192?lang=zh_cn&edition=full","pubTime":"2025-03-07 02:55","pubTimestamp":1741287354,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日02时55分，Mereo Biopharma Group Plc股票出现波动，股价急速下跌5.14%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为0.79%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为4847.52%、3638.89%、254.59%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为125.28%、122.63%、71.44%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司，专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307025554989ee2d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307025554989ee2d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","MREO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517607614","title":"Mereo Biopharma Group Plc盘中异动 下午盘股价大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517607614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517607614?lang=zh_cn&edition=full","pubTime":"2025-03-05 02:22","pubTimestamp":1741112566,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日02时22分，Mereo Biopharma Group Plc股票出现波动，股价急速拉升5.39%。截至发稿，该股报2.45美元/股，成交量103.912万股，换手率0.67%，振幅7.76%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为0.24%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司，专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030502224696397c89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030502224696397c89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","MREO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514085613","title":"Mereo Biopharma Group Plc盘中异动 早盘急速拉升5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514085613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514085613?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:31","pubTimestamp":1740580274,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时31分，Mereo Biopharma Group Plc股票出现异动，股价快速拉升5.16%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Enveric Biosciences, Inc.、Cns Pharmaceuticals, Inc.、Allarity Therapeutics, Inc.涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2625.96%、111.60%、85.05%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Silexion Therapeutics Corp、Eterna Therapeutics Inc.，振幅分别为6.75%、6.50%、6.37%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司，专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022622311596314f07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022622311596314f07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MREO","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514101657","title":"Mereo Biopharma Group Plc盘中异动 急速下跌5.02%报2.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514101657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514101657?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:44","pubTimestamp":1740498297,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时44分，Mereo Biopharma Group Plc股票出现异动，股价急速下挫5.02%。截至发稿，该股报2.56美元/股，成交量87.9469万股，换手率0.57%，振幅7.06%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体涨幅为0.94%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司，专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252344579630030e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252344579630030e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","MREO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514703855","title":"Mereo Biopharma Group Plc盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514703855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514703855?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:23","pubTimestamp":1740428581,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时23分，Mereo Biopharma Group Plc股票出现异动，股价快速下挫5.09%。截至发稿，该股报2.71美元/股，成交量60.9798万股，换手率0.39%，振幅5.85%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为0.21%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司，专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225042301abdb57d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225042301abdb57d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","MREO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509496450","title":"Mereo Biopharma Group Plc盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509496450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509496450?lang=zh_cn&edition=full","pubTime":"2025-02-05 04:24","pubTimestamp":1738700644,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日04时24分，Mereo Biopharma Group Plc股票出现波动，股价急速拉升5.02%。截至发稿，该股报3.14美元/股，成交量85.0602万股，换手率0.55%，振幅5.22%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体涨幅为1.33%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司，专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205042404abc2683b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205042404abc2683b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MREO","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507320650","title":"Mereo Biopharma Group Plc盘中异动 快速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507320650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507320650?lang=zh_cn&edition=full","pubTime":"2025-01-30 03:44","pubTimestamp":1738179895,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日03时44分，Mereo Biopharma Group Plc股票出现波动，股价急速上涨5.05%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体涨幅为1.47%。其相关个股中，Silexion Therapeutics Corp、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Silexion Therapeutics Corp、60 Degrees Pharmaceuticals, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为7151.78%、2355.25%、787.14%，振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Ocean Biomedical, Inc.、Silexion Therapeutics Corp，振幅分别为185.36%、120.82%、100.00%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司，专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130034455abbc9029&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130034455abbc9029&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","MREO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506986498","title":"Mereo Biopharma Group Plc盘中异动 临近午盘大幅下跌5.00%报2.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506986498","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506986498?lang=zh_cn&edition=full","pubTime":"2025-01-25 00:30","pubTimestamp":1737736221,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日00时30分，Mereo Biopharma Group Plc股票出现波动，股价大幅跳水5.00%。截至发稿，该股报2.95美元/股，成交量20.6662万股，换手率0.13%，振幅6.13%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为0.25%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司，专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125003021960fa28c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125003021960fa28c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MREO","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505026965","title":"Mereo Biopharma Group Plc盘中异动 急速拉升5.14%报3.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505026965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505026965?lang=zh_cn&edition=full","pubTime":"2025-01-24 04:59","pubTimestamp":1737665988,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日04时59分，Mereo Biopharma Group Plc股票出现波动，股价快速拉升5.14%。截至发稿，该股报3.07美元/股，成交量140.987万股，换手率0.91%，振幅7.71%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体涨幅为1.74%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司，专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124045948abb6459e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124045948abb6459e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MREO","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505271670","title":"Mereo Biopharma Group Plc盘中异动 早盘快速上涨5.94%报3.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505271670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505271670?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:42","pubTimestamp":1737470555,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时42分，Mereo Biopharma Group Plc股票出现波动，股价急速拉升5.94%。截至发稿，该股报3.03美元/股，成交量5.0591万股，换手率0.03%，振幅3.15%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体涨幅为0.88%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司，专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121224236960bbb82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121224236960bbb82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MREO","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504650942","title":"Mereo Biopharma Group Plc盘中异动 下午盘股价大跌5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504650942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504650942?lang=zh_cn&edition=full","pubTime":"2025-01-17 04:06","pubTimestamp":1737058014,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日04时06分，Mereo Biopharma Group Plc股票出现异动，股价快速下跌5.61%。截至发稿，该股报2.86美元/股，成交量134.564万股，换手率0.87%，振幅5.10%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为0.77%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司，专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011704065496064a1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011704065496064a1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MREO","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503457436","title":"Mereo Biopharma Group Plc盘中异动 急速跳水5.69%报3.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503457436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503457436?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:54","pubTimestamp":1736866484,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时54分，Mereo Biopharma Group Plc股票出现波动，股价大幅下跌5.69%。截至发稿，该股报3.15美元/股，成交量7.2824万股，换手率0.05%，振幅7.19%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为0.41%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司，专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114225444a221bde1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114225444a221bde1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","MREO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503585832","title":"Mereo Biopharma Group Plc盘中异动 早盘快速下跌6.89%报3.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503585832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503585832?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:32","pubTimestamp":1736778736,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时32分，Mereo Biopharma Group Plc股票出现波动，股价急速下跌6.89%。截至发稿，该股报3.31美元/股，成交量4.9175万股，换手率0.03%，振幅1.25%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为0.89%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司，专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223217a2203f19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223217a2203f19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MREO","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502089986","title":"Mereo Biopharma Group Plc盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502089986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502089986?lang=zh_cn&edition=full","pubTime":"2025-01-11 00:10","pubTimestamp":1736525439,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日00时10分，Mereo Biopharma Group Plc股票出现异动，股价快速下跌5.05%。截至发稿，该股报3.57美元/股，成交量22.6375万股，换手率0.15%，振幅4.65%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为1.50%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司，专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501110010399861fe35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501110010399861fe35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","MREO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500147121","title":"Mereo Biopharma Group Plc盘中异动 急速上涨5.41%报3.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500147121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500147121?lang=zh_cn&edition=full","pubTime":"2025-01-04 02:25","pubTimestamp":1735928740,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日02时25分，Mereo Biopharma Group Plc股票出现波动，股价急速上涨5.41%。截至发稿，该股报3.61美元/股，成交量36.9838万股，换手率0.24%，振幅4.97%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体涨幅为0.79%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司，专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104022540a21497a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104022540a21497a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","MREO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2495794525","title":"Mereo Biopharma Group Plc盘中异动 股价大跌5.09%报3.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495794525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495794525?lang=zh_cn&edition=full","pubTime":"2024-12-31 02:30","pubTimestamp":1735583401,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日02时30分，Mereo Biopharma Group Plc股票出现波动，股价急速下挫5.09%。截至发稿，该股报3.54美元/股，成交量36.6988万股，换手率0.24%，振幅5.23%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为1.04%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司，专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231023001ab9856fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231023001ab9856fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","MREO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493829640","title":"Mereo Biopharma Group Plc盘中异动 早盘急速上涨5.01%报3.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493829640","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493829640?lang=zh_cn&edition=full","pubTime":"2024-12-24 22:30","pubTimestamp":1735050651,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日22时30分，Mereo Biopharma Group Plc股票出现异动，股价快速拉升5.01%。截至发稿，该股报3.56美元/股，成交量1.8673万股，换手率0.01%，振幅0.88%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体涨幅为0.00%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司，专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224223051984d8334&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224223051984d8334&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MREO","BK4505"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mereobiopharma.com","stockEarnings":[{"period":"1week","weight":-0.0703},{"period":"1month","weight":-0.1722},{"period":"3month","weight":-0.0212},{"period":"6month","weight":-0.0286},{"period":"1year","weight":-0.8591},{"period":"ytd","weight":-0.324}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.0102},{"period":"3month","weight":0.0285},{"period":"6month","weight":0.0645},{"period":"1year","weight":0.1313},{"period":"ytd","weight":0.1145}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mereo BioPharma Group plc于2015年3月10日根据英格兰和威尔士法律注册成立。该公司是一家专注于罕见病创新疗法开发的生物制药公司。它已经建立了一个后期临床候选产品组合，包括用于成骨不全症的setrusumab和用于α-1抗胰蛋白酶缺乏相关肺部疾病的alvelestat。该公司的战略涉及有选择地获取和开发通过先前研发取得进展的罕见病候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.015037},{"month":2,"riseRate":0.428571,"avgChangeRate":0.010455},{"month":3,"riseRate":0,"avgChangeRate":-0.168155},{"month":4,"riseRate":0.571429,"avgChangeRate":0.09425},{"month":5,"riseRate":0.25,"avgChangeRate":-0.070465},{"month":6,"riseRate":0.625,"avgChangeRate":0.340287},{"month":7,"riseRate":0.625,"avgChangeRate":-0.038517},{"month":8,"riseRate":0.75,"avgChangeRate":0.064201},{"month":9,"riseRate":0.25,"avgChangeRate":-0.024678},{"month":10,"riseRate":0.375,"avgChangeRate":0.022782},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.101401},{"month":12,"riseRate":0.428571,"avgChangeRate":0.001557}],"exchange":"NASDAQ","name":"Mereo Biopharma Group Plc","nameEN":"Mereo Biopharma Group Plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mereo Biopharma Group Plc(MREO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Mereo Biopharma Group Plc(MREO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Mereo Biopharma Group Plc,MREO,Mereo Biopharma Group Plc股票,Mereo Biopharma Group Plc股票老虎,Mereo Biopharma Group Plc股票老虎国际,Mereo Biopharma Group Plc行情,Mereo Biopharma Group Plc股票行情,Mereo Biopharma Group Plc股价,Mereo Biopharma Group Plc股市,Mereo Biopharma Group Plc股票价格,Mereo Biopharma Group Plc股票交易,Mereo Biopharma Group Plc股票购买,Mereo Biopharma Group Plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mereo Biopharma Group Plc(MREO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Mereo Biopharma Group Plc(MREO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}